RCL
76
3
HCP
56
2
DOV
50
2
APH
58
5
ETR
65
4
MS
70
6
KMX
58
6
RF
44
3
AMT
33
3
WMB
62
2
PX
58
5
HST
57
4
GLW
48
4
EQT
48
6
MRK
27
2
ZTS
40
2
MAR
60
3
ORLY
52
5
NEE
44
3
HOG
29
2
RCL
76
3
HCP
56
2
DOV
50
2
APH
58
5
ETR
65
4
MS
70
6
KMX
58
6
RF
44
3
AMT
33
3
WMB
62
2
PX
58
5
HST
57
4
GLW
48
4
EQT
48
6
MRK
27
2
ZTS
40
2
MAR
60
3
ORLY
52
5
NEE
44
3
HOG
29
2
Financhill
Back

ProPhase Labs Stock Price Chart

FREE REPORT: 2025 Gold Price Outlook

Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
15

PRPH
ProPhase Labs

Last Price:
$0.63
Seasonality Move:
15.03%

7 Day Trial

ALL ACCESS PASS

$ 7

2025 Gold Forecast: A Perfect Storm for Demand

Discover our Gold Price Outlook for 2025--FREE--here
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRPH is experiencing selling pressure, which indicates risk of future bearish movement.

ProPhase Labs Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 0.66 Sell
20-day SMA: 0.7 Sell
50-day SMA: 1.27 Sell
200-day SMA: 3.36 Sell
8-day EMA: 0.65 Sell
20-day EMA: 0.74 Sell
50-day EMA: 1.18 Sell
200-day EMA: 2.88 Sell

ProPhase Labs Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 27.47 Sell
Chaikin Money Flow: -41125 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.66 - 0.76) Sell
Bollinger Bands (100): (1.06 - 2.72) Sell

ProPhase Labs Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for ProPhase Labs Stock

Is ProPhase Labs Stock a Buy?

  • ProPhase Labs share price is 0.63 while PRPH 8-day simple moving average is 0.66, which is a Sell signal.
  • The stock price of PRPH is 0.63 while ProPhase Labs 20-day SMA is 0.70, which makes it a Sell.
  • ProPhase Labs 50-day simple moving average is 1.27 while PRPH share price is 0.63, making it a Sell technically.
  • PRPH stock price is 0.63 and ProPhase Labs 200-day simple moving average is 3.36, creating a Sell signal.

PRPH Technical Analysis vs Fundamental Analysis

Sell
15
ProPhase Labs (PRPH) is a Sell

Is ProPhase Labs a Buy or a Sell?

  • ProPhase Labs stock is rated a Sell
    The current ProPhase Labs [PRPH] share price is $0.63. The Score for PRPH is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.

ProPhase Labs Stock Info

Market Cap:
15M
Price in USD:
0.63
Share Volume:
41.1K

ProPhase Labs 52-Week Range

52-Week High:
7.48
52-Week Low:
0.61
Sell
15
ProPhase Labs (PRPH) is a Sell

ProPhase Labs Share Price Forecast

  • What is the ProPhase Labs stock price today?
    The ProPhase Labs stock price is 0.63 USD today.
  • Will PRPH stock go up or go down?
    ProPhase Labs> share price is forecast to RISE/FALL based on technical indicators
  • Is ProPhase Labs overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, ProPhase Labs is overvalued.

Is ProPhase Labs Stock a Buy?

  • ProPhase Labs share price is 0.63 while PRPH 8-day exponential moving average is 0.65, which is a Sell signal.
  • The stock price of PRPH is 0.63 while ProPhase Labs 20-day EMA is 0.74, which makes it a Sell.
  • ProPhase Labs 50-day exponential moving average is 1.18 while PRPH share price is 0.63, making it a Sell technically.
  • PRPH stock price is 0.63 and ProPhase Labs 200-day simple moving average is 2.88, creating a Sell signal.

Fundamental Analysis of ProPhase Labs

Is ProPhase Labs a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and an increase next year of $0.43 per share.

Technical Analysis of ProPhase Labs

Should I short ProPhase Labs stock?

* ProPhase Labs stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.